Search is restricted to the following diseases:
Search Results for "IKBKG" - 35 interactions found in 10 entries.
|
|
|
Interactor1 (Subject) |
|
Interaction type |
Interactor2 (Object) |
additional information |
|
|
|
|
925
|
| 5615 |
PRKN
|
|
increases_ubiquitination/sumoylation of
|
IKBKG
|
|
| 5619 |
PRKN
|
NOT |
affects_quantity of
|
IKBKG
|
via ubiquitin-mediated proteasomal degradation
|
|
17314283
|
Parkinson disease
|
|
1,668
|
| 12292 |
IKBKG
|
|
affects_activity of
|
Insulin resistance
|
in NEMO(L-KO) mouse, if insulin resistance is obesity-associated and NFkappaB mediated
|
| 12298 |
IKBKG
|
|
affects_activity of
|
Fatty liver disease, nonalcoholic
|
|
| 12301 |
IKBKG
|
|
affects_expression of
|
PPARA
|
in liver
|
| 12302 |
IKBKG
|
|
affects_activity of
|
fatty acid beta-oxidation
|
in liver
|
| 12351 |
IKBKG
|
|
affects_expression of
|
PPARG
|
in liver
|
| 12352 |
IKBKG
|
|
affects_expression of
|
SREBF1
|
in liver
|
| 12353 |
IKBKG
|
|
affects_expression of
|
FASN
|
in liver
|
| 12354 |
IKBKG
|
|
affects_quantity of
|
macrophage
|
in liver; after normal chow diet, after high-fat diet
|
| 12355 |
IKBKG
|
|
affects_activity of
|
inflammatory response
|
in liver; after normal chow diet, after high-fat diet
|
| 12356 |
IKBKG
|
|
affects_expression of
|
TNF
|
in liver; after high-fat diet
|
| 12357 |
IKBKG
|
|
affects_expression of
|
CCL2
|
in liver; after high-fat diet
|
| 12358 |
IKBKG
|
NOT |
affects_activity of
|
inflammatory response
|
in adipose tissue; in NEMO(L-KO) mouse, after high-fat diet
|
| 12359 |
IKBKG
|
|
affects_quantity of
|
IL6
|
in blood; after high-fat diet
|
| 12360 |
IKBKG
|
|
affects_phosphorylation of
|
STAT3
|
after high-fat diet, at Tyr residues of STAT3
|
| 12361 |
IKBKG
|
|
affects_activity of
|
interleukin-6-mediated signaling pathway
|
in liver; after high-fat diet
|
| 12362 |
IKBKG
|
|
affects_activity of
|
apoptotic process
|
in liver; after high-fat diet
|
| 12363 |
IKBKG
|
|
affects_activity of
|
Hepatocellular carcinoma
|
in liver; after high-fat diet
|
|
18216263
|
Hepatocellular carcinoma
Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
|
|
6,972
|
| 68385 |
TRAF6
|
|
increases_activity of
|
IKBKG
|
via ubiquitination
|
| 68386 |
TRAF6
|
|
increases_ubiquitination/sumoylation of
|
IKBKG
|
|
| 68438 |
IKBKG
|
|
is_part_of
|
I-kappa-B kinase complex
|
via ubiquitination
|
|
21252204
|
Inflammatory bowel disease
|
|
6,983
|
| 68505 |
IKBKG
|
|
decreases_activity of
|
colitis
|
|
| 68506 |
IKBKG
|
|
increases_activity of
|
NF-kappaB complex
|
|
| 69404 |
IKBKG
|
|
affects_expression of
|
DEFB103A
|
in mouse primary colonic epithelial cells
|
|
17361131
|
Inflammatory bowel disease
Inflammation
|
|
7,044
|
| 69044 |
MALT1
|
|
increases_ubiquitination/sumoylation of
|
IKBKG
|
together with BCL10
|
| 69089 |
TRAF6
|
|
increases_ubiquitination/sumoylation of
|
IKBKG
|
in Jurkat cells; in the presence of the ubiquitin-conjugating enzyme (E2) complex UBC13-UEV1A
|
| 69113 |
IKBKG
|
|
increases_activity of
|
TAK1 complex
|
|
| 69125 |
Ubiquitin-conjugating enzyme E2 (UBC13-UEV1A)
|
|
increases_ubiquitination/sumoylation of
|
IKBKG
|
in Jurkat cells; in the presence of the ubiquitin-conjugating enzyme (E2) complex UBC13-UEV1A
|
|
|
Inflammation
|
|
9,435
|
| 100440 |
protein K63-linked ubiquitination
|
|
increases_activity of
|
IKBKG
|
|
|
30102008
|
Cardiomyopathy, hypertrophic
|
|
9,558
|
| 101340 |
TRIM37
|
|
affects_activity of
|
IKBKG
|
via ubiquitination
|
|
30586926
|
Mulibrey nanism
|
|
11,525
|
| 115018 |
TBK1
|
|
interacts (colocalizes) with
|
IKBKG
|
after viral infection
|
| 115019 |
IKBKG
|
|
increases_activity of
|
TBK1
|
after viral infection
|
|
26611359
|
Immunological
Inflammation
|
|
11,540
|
| 115144 |
FAM161A
|
|
interacts (colocalizes) with
|
IKBKG
|
|
|
25749990
|
Ophtalmological
|
|
12,231
|
| 120108 |
TANK
|
|
interacts (colocalizes) with
|
IKBKG
|
|
|
21931631
|
Viral infection
|
CIDeRplus